vTv Therapeutics Q2 EPS $(1.05) Misses $(0.99) Estimate
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.99) by 6.06 percent. This is a 14.13 percent decrease over losses of $(0.92) per share
vTv Therapeutics lost more money per share than experts thought it would, and things got worse compared to last year. When a company's losses grow bigger, it's a sign to watch whether they're getting closer to making money or spending too much.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.